COVID-19 Treatment GuidelinesPage 8 of 15

6. Antiviral Drugs

Summary

A gloved hand holding a vaccine bottle.

National Institutes of Health

This section focuses on the COVID-19 Treatment Guidelines Panel’s (the Panel) recommendations for using small-molecule antiviral drugs to treat COVID-19.

Remdesivir remains the only drug that is approved by the Food and Drug Administration for the treatment of COVID-19. Ritonavir-boosted nirmatrelvir (Paxlovid), molnupiravir, and certain anti-SARS-CoV-2 monoclonal antibodies (mAbs) have received Emergency Use Authorizations from the FDA for the treatment of COVID-19. 

This section also provides information about antiviral drugs that are not recommended for the treatment of COVID-19.

Instructions

  1. Click on the PDF link below to access this section.
  2. Return to this page. Click “Next” below access the next section.
  3. The last section provides a link to the quiz, registration, payment, and certificate.
PDF icon Section 6: Antiviral Drugs
Back Next